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Objectives. This study sought to evaluate the short-term results 
and long-term outcome of percutaneous revascularization of ostial 
saphenous vein graft stenoses in a large patient series. 
Background. Previous studies have demonstrated that the 
results of balloon angioplasty for native coronary ostial stenoses 
are significantly worse than those for nonostial esions. However, 
it is controversial whether interventions in patients with ostial 
saphenous vein grafts carry a similar prognosis. 
Methods. We identified 68 consecutive patients with ostial 
(group I) and 72 consecutive patients with proximal, nonostial 
(group H) saphenous vein graft stenoses who underwent percuta- 
neous angioplasty or directional atherectomy for a single new 
stenosis at the Cleveland Clinic between 1986 and 1992. 
Results. Success was achieved in 61 patients (89.7%) in group I 
and 64 (88.9%) in group II (p = 0.88). There were no di[erences 
in major procedural complications (death, Q wave infarction and 
bypass surgery) between the two groups. At a mean (_+SD) 
follow-up of 23 _+ 17 months, 36 patients (64%) in group I had one 
or more adverse events (death, infarction, repeat coronary revas- 
cularization or cardiac-related hospital admission) compared 
with 34 patients (58%) in group II (p = 0.87). Twenty.eight 
patients (50%) were angina free in group I compared with 33 
(56%) in group II (p = 0.65). During the follow-up period in 
group I, 7 patients died (13%), 10 had a myocardial infarction 
(18%), 11 had repeat bypass surgery (20%), 8 had repeat percu- 
taneous interventions (14%), and 30 had one or more cardiac- 
related hospital admissions (54%). The incidence of these events 
was similar in group II except for a slightly higher incidence of 
myocardial infarction: 6 patients died (10%), 3 had a myocardial 
infarction (5%), 12 had repeat bypass surgery (20%), 12 had 
repeat percutaneous interventions (20%), and 26 had one or more 
cardiac-related hospital admissions (44%). 
Conclusions. Unlike ostial native coronary disease, the clinical, 
procedural and follow-up profile of ostial saphenous vein graft 
rcvascularization is not significantly worse than proximal nonos- 
tial disease. This finding may be related to the overall suboptimal 
results of percutaneous revascularization i saphcnous vein grafts 
compared with native coronary arteries or to the unfavorable 
intrinsic properties of ostial native coronary arteries compared 
with ostial vein grafts. 
(J Am CoU Cardiol 1995;26:955-60) 
Several studies (1-5) have demonstrated that the short- and 
long-term results of angioplasty of saphenous vein grafts are 
superior when the procedure involves the distal anastomotic 
site compared with the proximal or midsegments ofthe grafts. 
However, whether the poor results of angioplasty of the 
proximal segments of vein grafts are related to a "true" ostial 
location of the stenoses or other factors inherent in the 
proximal segment of the vein graft as a whole has not been 
addressed. 
Studies of balloon angioplasty of native coronary arteries 
(6,7) have shown significantly worse results for coronary ostial 
stenoses than for nonostial lesions, with low rates of proce- 
dural success and high rates of acute complications and 
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restenosis. These poor results have b en explained by technical 
difficulties during the procedure and the atypical composition 
of the coronary ostial lesions (8,9) and have prompted the use 
of new devices (i.e., rotational atherectomy, excimer laser 
angioplasty or stents) for the treatment of ostial native coro- 
nary stenoses in an attempt to improve the short- and long- 
term results of these procedures. The use of these new devices 
has been extrapolated to ostial saphenous vein grafts based, in 
part, on the reported unfavorable experience of angioplasty of 
ostial native and ostial renal artery stenoses (6,10,11). 
An attempt o characterize ostial s phenous vein grafts 
separately from proximal nonostial vein segments is not simply 
of academic interest, ra her, it might clarify whether ostial vein 
graft stenoses themselves do indeed necessitate different or 
additional interventions compared with proximal nonostial 
vein stenoses, in the same way that ostial native stenoses 
necessitate different or additional interventions compared with 
proximal nonostial native stenoses. 
The present study was undertaken to evaluate the short- 
term results and long-term outcome of percutaneous revascu- 
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larization of ostial saphenous vein grafts compared with that 
for proximal nonostial saphenous vein grafts in a large series of 
patients with ostial saphenous vein graft revascularization. The 
results of long-term follow-up of these patients and their 
relation to the ostial location of the stenoses are also pre- 
sented. 
Methods 
Patients. The Cleveland Clinic Interventional Database 
was accessed to identify all patients undergoing percutaneous 
transluminal angioplasty or directional atherectomy for a 
single new ostial or proximal stenosis of saphenous vein grafts 
between January 1986 and January 1992. Patients with acute 
myocardial infarction within 36 h and those with total occlu- 
sions were excluded. We identified 68 consecutive patients with 
ostial (group I) and 72 consecutive patients with proximal 
nonostial (group II) saphenous vein graft stenoses who consti- 
tuted the study group. 
Procedural techniques. The angioplasty and atherectomy 
procedures were performed as described in detail elsewhere 
(12,13). Routine preprocedural and postprocedural care were 
followed for all patients, including pretreatment with aspirin 
and a calcium channel blocking agent. Intravenous heparin 
(10,000 to 15,000 U) was administered atthe beginning of the 
procedure, followed by additional boluses as needed. After 
completion of the procedure, the patients were monitored in 
an intensive care unit or a postprocedure telemetry ward. An 
electrocardiogram was routinely recorded after the procedure, 
on the following day, and in the event of any chest pain 
suggesting ischemia. P tients received maintenance therapy 
with aspirin, and a calcium channel blocker was administered 
for at least 48 h after the procedure. 
Clinical and procedural variables. Clinical information at 
the time of the initial presentation and data obtained at thc 
time of the procedure and at discharge were recorded prospec- 
tively on standard case report forms and entered into the 
Cleveland Clinic Interventional Database. An experienced 
angiographer reviewed the diagnostic and procedural cinean- 
giograms to code for lesion-related morphologic variables 
(eccentricity, length, calcification, complex and thrombus- 
containing lesions). Angiographic measurements before and 
after the procedure were performed by using hand-held cali- 
pers in the projection showing the most severe stenosis, with 
the guiding catheter serving as the reference standard. Anglo- 
graphic data were also entered prospectively into the registD, 
data base. 
Follow-up. Clinical follow-up data were obtained by 
trained Interventional Registry. personnel who made telephone 
contact calls with the referral patients in this study and by visits 
of patients followed up at our institution. The patients were 
questioned as to the recurrence of symptoms, myocardial 
infarction, coronary revascularization and cardiac-related hos- 
pital admission (for angina, heart failure or arrhythmias). 
Follow-up events were analyzed and classified by a physician. 
Table 1. Clinical Demographics for 140 Study Patients 
Ostial Lesions Nonostial Lesions p 
(n - 68) (n = 72) Value 
Mean age (yr) 63 62 0.62 
Gender (?4 male) 82 72 0.15 
Previous myocardial infarction (%) 44 53 0.39 
Unstable angina (%) 71 72 0.65 
LVEF <0.45 (%) 24 36 0.54 
Risk factors 
Smoking (%) 71 66 0.67 
Diabetes (%) 25 34 0.26 
Hypertension (%) 64 59 0.54 
Family histo~, (%) 46 42 0.51 
Cholesterol >200 mg/dl (%) 52 56 0.68 
LVEF = left ventricular ejection fraction. 
Definitions. Ostial stenosis was defined as a lesion >50% 
diameter reduction within 3 mm of the vessel orifice. Proximal 
nonostial stenosis was defined as a lesion localized in the 
proximal one-third of the vein graft but not within 3 mm of the 
ostium. Success was defined as an increase ->20% in lumen 
diameter with a final percent diameter stenosis <50% and no 
major complications. Major complications were considered 
bypass surgery, Q wave myocardial infarction or death and 
were defined according to the National Heart, Lung and Blood 
Institute definitions (14). The angiographic definitions used in 
this analysis have been used in the evaluation of the results of 
angioplasty and atherectomy and were previously published 
elsewhere (15,16). 
Statistical analysis. Statistical analysis was performed us- 
ing a computerized statistical analysis program (SAS Institute 
Inc.). The two groups were compared using the chi-square test 
or the Fisher exact est to test differences incategoric variables. 
The Student t test was used to assess differences incontinuous 
variables. A significance level of 0.05 was assumed. On the 
basis of sample size, the study had an 80% power to detect a 
16% difference in procedural success between the two groups 
(one-sided test; alpha level of 0.05). 
Results 
Demographics. The baseline patient information for each 
of the two groups was comparable (Table 1). The patients in 
this study were predominantly men with unstable angina and 
preserved left ventricular function. Hypertension, hypercholes- 
terolemia nd a family history of coronary artery disease were 
prevalent in these patients. 
Morphologic and procedural characteristics. The ages of 
the saphenous vein grafts were similar for the two groups 
(Table 2), Most of the stenoses were discrete and eccentric. 
There was a slightly higher incidence of diffuse disease in the 
nonostial saphenous vein graft group and a trend toward more 
complex lesions in the same group. There was no difference in
the number of inflations or maximal inflation pressure for the 
two groups. 
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Table 2. Morphologic and Procedural Characteristics 
Ostial Nonostial p 
Lesions Lesions Value 
Graft age (too) 68 75 0.45 
Lesion morphology 
Lesion length (ram) 6 7 0.06 
Discrete l sion (%) 54 57 0.98 
Eccentric lesion (%) 47 63 0.40 
Diffuse disease (%) 2 13 0.04 
Calcified lesion (%) 2 3 0.95 
Filling defect (%) 9 19 0.19 
Complex lesion (%) 6 18 0.09 
Vessel grafted (%) 
LAD 39 32 1 
RCA 23 35 t 0.29 
Cx 38 33 
Procedure 
Stand-alone angioplasty (9~) 71 67 (/.88 
Atherectomy -+ angioplasty (%) 29 33 
No. of inflations* 3 4 0.19 
Maximal pressure (atm)* 9 9 (}.97 
*For angioplasty procedures. Data presented are mean value or percent of 
patients. Cx = circumflex coronary, tery; LAD = left anterior descending 
coronary artery; RCA = right coronary artery. 
Procedural results. Success was achieved in 61 patients in 
group I (89.7%) versus 64 patients in group II (88.9%, p = 
0.88) (Table 3). Failures occurred in saphenous vein grafts 
supplying the distribution of the left anterior descending 
coronary artery in five patients, right coronary artery in seven 
and circumflex artery in three. There was no difference in 
percent stenosis before or after the procedure. In group I there 
were one death, one Q wave infarction and two bypass urgery 
procedures. Three patients in group I had unsuccessful, un- 
complicated procedures. In group II, there were three deaths, 
two Q wave infarctions and four bypass surgery procedures. 
Three of the four repeat bypass urgery procedures in group II 
were performed emergently. One patient had persistent hypo- 
tension after operation and died shortly thereafter. The other 
two patients underwent successful repeat bypass surgery and 
had a non-Q wave myocardial infarction only. Two patients in 
group I and three in group II had a non-Q wave infarction. 
Table 3. Procedural Results 
Ostial Lesions Nonostial Lesions p 
(n - 6g) (n - 72) Value 
Success 61/68 {89.79,~) 64/72 (88.9%) 0.88 
Stenosis 
Preprocedure 85q 86% ii.71 
Postprocedure 24% 22% 0.60 
Death 1 ( 1.5~:, ) 3 (4.2%) 0.62 
Q wave infarction 1 ( 1.5c'c ) 2 (2.8%) 1.00 
Non-Q wave infarction 2 (2.9~) 3 (4.2%) 1.(10 
Bypass surgery 2 (2.99~) 4 (5.6%) 0.68 
Data presented are number or percenl tff patients. 
There were no significant differences in major procedural 
complications between the two groups. 
Follow-up. The mean (+SD) follow-up period was 23 _+ 17 
months. Seven patients lived in foreign countries and were 
therefore xcluded from follow-up. Clinical follow-up results 
were available for 115 (97.5%) of 118 patients with successful 
procedures: 56 patients in group I and 59 in group II. Three 
patients were lost to follow-up. During the follow-up period, 36 
patients (64%) in group I had one or more adverse events 
(death, infarction, repeat bypass urgery, repeat percutaneous 
intervention or cardiac-related hospital admission) compared 
with 34 patients (58%) in group II (p = 0.87). In group I, 7 
patients died (13%), 10 had a myocardial infarction (18%), 11 
had repeat bypass surgery (20%), 8 had repeat percutaneous 
interventions (14%), and 30 (54%) had one or more cardiac- 
related hospital admissions. The incidence of these events was 
similar in group II except for a slightly higher, statistically 
nonsignificant incidence of myocardial infarction: 6 patients 
died (10%), 3 had a myocardial infarction (5%), 12 had repeat 
bypass surgery (20%), 12 had repeat percutaneous interven- 
tions (20%), and 26 patients (44%) had one or more cardiac- 
related hospital admissions. At the end of the follow-up period, 
28 patients (50%) were angina free in group I compared with 
33 (56%) in group II (p = 0.65). 
Discuss ion  
The results of balloon angioplasty of ostial native coronary 
lesions have been reported to be much worse than those of 
nonostial lesions (6,7). In the only substantial series of patients 
with aortocoronary lesions, Topol et al. (6) described the 
results of balloon angioplasty in 53 patients with right coronary 
artery ostial stenoses and reported low rates for procedural 
and long-term success (79% and 49%, respectively) and high 
rates for procedural complications (9% for emergency bypass 
surgery, 48% for clinical recurrence and 38% for restenosis) 
despite a favorable risk profile within their patient cohort. 
Mathias et al. (7) reported similar results for stenoses at the 
ostium of a coronary branch vessel. 
These unfavorable results of percutaneous revasculariza- 
tion of ostial native coronaries and similar unfavorable results 
of angioplasty of ostial renal artery stenoses have been extrap- 
olated to percutaneous revascularization f ostial saphenous 
vein grafts, and it has been suggested (11) that the results of 
angioplasty of proximal vein graft anastomoses are similarly 
unfavorable as the reported experience with ostial right coro- 
nary artery and ostial renal artery stenoses. A few small series 
studying ostial saphenous vein grafts as subgroups of larger 
studies have also suggested that angioplasty of ostial saphe- 
nous vein graft carries an adverse prognosis compared with 
that for nonostial disease (Table 4). The initial success rates of 
angioplasty of the proximal segments (including ostial steno- 
ses) in these series varied from 50% to 94%, with a combined 
overall success of 84% compared with a success rate of 67% to 
100% and a combined overall success rate of 93% for angio- 
plas~ of the midsegment ofvein grafts (Table 4). However, no 
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Table 4. Initial Success and Restenosis Rates After Angioplasty ofProximal and Mid-Saphenous Vein Grafts* 
Initial Success Restenosis 
Ref 
No. Ostial Proximal (+ostial) Mid Ostial Proximal (+ostial) Mid 
1 NR 4/5 (80%) 22/23 (969~) NR 1/2 (50%) 9/17 (53%) 
26t NR NR NR 3/7 (43%) 10/19 (53%) 0/8 (0%) 
33 NR NR NR 1/2 (50%) 1/2 (50%) 8/15 (53%) 
31 NR 10/12 (83~) 7/8 (88%) NR 8i10 (80%) 2/7 (29%) 
17 NR 23/26 (88% I 7/7 (100%) NR NR (31%) NR (23%) 
34 NR NR NR NR 2/3 (67%) 3/5 (60%) 
35 NR NR NR NR 11/14 (79%) 40/65 (62%) 
21t NR NR NR 3/9 (33%) 5/19 (26%) 2/7 (29%) 
18 NR 11/14 (79~) 8/8 (100%) NR 3/5 (60%) 3/7 (43%) 
22 NR 34/36 (94%) 26/29 (90%) 1/3 (33%) 1/3 (33%) 3/5 (60%) 
19 NR 5/9 (56c,, ~) 2/3 (67%) NR NR NR 
20 NR 47/53 (89%) 24/24 (100%i NR 21/42 (50%) 9/20 (45%) 
3 NR 47/59 (80%) 39/45 (86~) NR NR (60%) NR (46%) 
36 NR 24/28 (86% I 32/33 (97~) N R NR NR 
4 NR NR NR NR 7/11 (64%) 20/32 (63%) 
25:]: NR NR NR NR 1/5 (20%,) 7/25 (28%) 
5 NR 4/8 (50~) NR NR 5/6 (83%) 4/10 (40%) 
Total NR 209/250 (84%) 167/180 (93%) 8/21 (38%) 76/141 (54%) 110/223 (49%) 
*Includes all published studies of angioplasty of saphenous vein grafts that reported the success or restenosis rates classified by vein graft segment, No correlation 
between site of stenosis and initial success reported. -No correlation between site of stenosis and restenosis reported. Data presented are number (%) of patients. NR = 
not reported; Ref - reference. 
study addressed the success rates for ostial stenoses separately. 
The restenosis rates from these studies varied from 31% to 
83% for proximal segments with a combined rate of 54% 
compared with rates of 0% to 63% with a combined rate of 
49% for midsegments (Table 4). These results prompted the 
recommendation that angioplasty of ostial vein graft stenoses 
should be undertaken with much less enthusiasm and initiated 
a great interest in nonballoon strategies for this site. However, 
the long-term outcome after nonballoon interventions i not 
yet known, and a relatively short follow-up period of 6 to 12 
months indicates that restenosis occurs in -60% of patients 
after laser angioplasty and in 40% to 50% after rotational or 
extraction atherectomy (2). 
Although several investigators (1,2,5,17-20) have suggested 
that lesions at the proximal anastomosis generally yield less 
favorable initial nd long-term results compared with other 
sites, other studies (21-26) did not corroborate hese findings. 
Also, the reported results of angioplasty of ostial saphenous 
vein grafts are based on a very small number of patients who 
were evaluated as subgroups of the original studies, and the 
vast majority of these studies included ostial stenoses and 
proximal shaft stenoses in the same group (Table 4). Indeed, 
the small number of patients who underwent angioplasty for 
true "ostial" vein stenoses in these studies showed restenosis 
rates of 33% to 50% (Table 4). However, the very small 
number of patients and the inadequacy of follow-up preclude 
an ability to draw meaningful conclusions. A related issue is 
that the disappointing results noted earlier for balloon angio- 
plasty may reflect he procedure as practiced in the early 1980s. 
Indeed, results of recent series of patients with aortoostial 
lesions treated by balloon angioplasty suggest that improved 
immediate success and a lower incidence of complications may 
be attainable (21,22,24,25). However, the computation of 
pooled success and restenosis rates in Table 4 has to be 
interpreted with caution because it is impossible toaccount for 
"between-study" differences. 
The overall unfavorable results of angioplasty of ostial 
native coronary arteries have been explained in part by tech- 
nical ditficulties encountered during the procedure. Guide 
catheter seating is often inadequate, making manipulation 
dill]cult. Further, with guide catheter intubation, trauma to the 
diseased intima may lead to dissection and abrupt closure. 
Atypical lesion composition is a further possible explanation 
for the suboptimal results associated with these stenoses. Some 
investigators have suggested congenital arterial hypoplasia 
with age-related intimal thickening (27) and the presence of a 
muscular sphincter at the ostium (28). In addition, the vessel 
ostium contains regions in which t ere is high wall shear stress, 
which has been suggested (29) to predispose to intimal fibrosis, 
endothelial damage nd subsequent platelet deposition. Such 
lesions may be resistant to dilation (requiring high inflation 
pressures to "crack") and may show exaggerated elastic recoil 
with consequent procedural failure or restenosis (9). Patholog- 
ically, the ostial saphenous vein graft site presents an entirely 
different problem compared with ostial native lesions. In 
addition to the inherent distinctions between vein and artery, 
the surgical anastomosis itself involves an artificial opening in 
the thick elastic wall of the aorta and cannot be viewed as 
similar to a native ostium. Stenoses in this area, unlike ostial 
native disease, have be n attributed (11,30,31) to excessively 
acute angulation of the graft from the aortic wall or too large 
an aortotomy. These lesions are usually not calcified and 
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originate from a funnel-shaped anastomosis and may therefore 
behave differently from ostial native disease. 
More recent studies (21,22,24) specifically evaluating ostial 
saphenous vein graft stenoses found that lesions at this site are 
not a significant predictor of failure. Using a stepwise multiple 
regression analysis, Cote et al. (21) showed that the percent 
diameter stenosis immediately after dilation was the strongest 
predictor of percent diameter stenosis at follow-up. In their 
series, there was no significant difference in postangioplasty 
percent diameter stenosis at the various sites in the grafts, 
leading Cote et al. (21) to suggest hat perhaps the higher 
residual stenosis at angioplasty at the proximal anastomotic 
site may explain the higher recurrence rat s previously noted. 
Our findings confirm the conclusions of these recent studies 
and show that unlike ostial native disease, the clinical, proce- 
dural and follow-up profile of ostial saphenous vein grafts 
is not significantly worse than that for proximal nonostial 
disease. 
These findings contrasted markedly with our experience in 
percutaneous revascularization f ostial native coronary steno- 
ses over the same time period (32). In a group of 1,150 
patients, we reported a significantly lower success rate for 
ostial native coronary stenoses compared with that for proxi- 
mal nonostial stenoses (81% vs. 90%, p = 0.02). Compared 
with patients with proximal nonostial native disease, patients 
with ostial native coronary disease were older (62 vs. 59 years, 
p = 0.03), included more women (38% vs. 27%, p = 0.03) and 
had more calcified lesions (9% vs. 3%, p < 0.0001). There was 
a higher esidual stenosis in this group (33% vs. 24%, p = 0.01) 
and a relatively high incidence (14.1%) of in-hospital proce- 
dure-related complications (death, Q wave infarction, emer- 
gency bypass surgery). This experience is consistent with the 
previously reported results (6,7) of percutaneous revascular- 
ization in patients with ostial native coronary disease. 
Study limitations. This is a retrospective analysis; it i  
possible that other known risk factors, not assessed in the 
present study, might have added prognostic information. Al- 
though, to our knowledge, this is the largest reported series of 
percutaneous revascularization f ostiai saphenous vein grafts, 
the number of patients is still relatively small, nd therefore, 
beta-error cannot be excluded. Also, because of the small 
number of patients undergoing other new interventional mo- 
dalities during the time frame of the study (1986 to 1992), we 
did not assess the results of newer percutaneous interventions, 
which hold promise for the treatment ofostial lesions (excimer 
laser angioplasty, rotational atherectomy and stenting). 
Conclusions. In a large series of patients, this study shows 
that unlike ostial native disease, the clinical, procedural and 
follow-up profile of ostial saphenous vein graft percutaneous 
revaseularization is not significantly worse than that for prox- 
imal nonostial disease. This finding may be related to the 
overall suboptimal results of percutaneous revascularization in 
saphenous vein grafts compared with native coronary arteries 
or unfavorable intrinsic properties of ostial native coronary 
arteries compared with ostial saphenous vein grafts. We pro- 
pose that angioplasty and atherectomy are viable methods for 
percutaneous revascularization atthis site and should not be 
excluded in trials evaluating the results of newer revascular- 
ization options for patients with ostial saphenous vein graft 
disease. 
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